Order results by:
Issue | Title | |
Vol 3, No 2 (2007) | VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY | Abstract similar documents |
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes | ||
"... Indirect anticoagulants effectively prevent thromboembolic complications in patients with high ..." | ||
Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
"... is accorded by hemorrhages with lower frequency than therapy by indirect anticoagulants, but really exist. New ..." | ||
Vol 13, No 3 (2017) | PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION | Abstract similar documents |
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko | ||
"... parameters of new oral anticoagulants. The review presents data from studies investigating the effect of gene ..." | ||
Vol 2, No 3 (2006) | EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS | Abstract similar documents |
A. P. Momot, O. V. Bespalova, E. N. Vorobyova | ||
"... The anticoagulants of indirect action during many years serve drugs of basic prophylaxis ..." | ||
Vol 9, No 4 (2013) | COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS | Abstract similar documents |
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova | ||
"... Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban ..." | ||
Vol 9, No 5 (2013) | APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA | Abstract similar documents |
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev | ||
"... response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral ..." | ||
Vol 16, No 5 (2020) | New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
K. B. Mirzaev, D. V. Ivashchenko, I. V. Volodin, E. A. Grishina, K. A. Akmalova, A. A. Kachanova, A. I. Skripka, R. M. Minnigulov, T. E. Morozova, O. A. Baturina, A. N. Levanov, T. V. Shelekhova, A. I. Kalinkin, D. A. Napalkov, A. A. Sokolova, D. A. Andreev, I. N. Sychev, P. O. Bochkov, D. A. Sychev | ||
"... ), who had hemorrhagic complications during taking direct oral anticoagulants. To find new ..." | ||
Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
Yu. P. Skirdenko, N. A. Nikolaev | ||
"... Aim. To evaluate the effectiveness of the anticoagulant choice algorithm in the prevention ..." | ||
Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..." | ||
Vol 14, No 1 (2018) | NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
Ju. P. Skirdenko, N. A. Nikolayev | ||
"... as predictors of choice of optimal anticoagulant therapy in patients with atrial fibrillation (AF). Material ..." | ||
Vol 12, No 2 (2016) | THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE | Abstract similar documents |
S. V. Moiseev | ||
"... (dabigatran), today are increasingly replacing warfarin and other indirect anticoagulants in preventing stroke ..." | ||
Vol 5, No 3 (2009) | ANTICOAGULANTS IN ACUTE CORONARY SYNDROME | Abstract similar documents |
I. A. Latfullin, A. A. Podolskaya | ||
Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
"... ) in patients receiving continuous direct oral anticoagulant (DOAC) therapy. Material and methods. Data from ..." | ||
Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova | ||
"... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
Vol 16, No 5 (2020) | Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage | Abstract similar documents |
N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
"... Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants ..." | ||
Vol 14, No 1 (2018) | UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME | Abstract similar documents |
O. V. Krikunova, R. I. Stryuk | ||
"... Anticoagulant therapy is widely used in all forms of acute coronary syndrome (ACS) to inhibit ..." | ||
Vol 10, No 4 (2014) | MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva | ||
"... anticoagulants. ..." | ||
Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
A. V. Rudakova | ||
"... oral anticoagulants (NOACs). Material and methods. Cost-effectiveness analysis was performed using ..." | ||
Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
"... Aim. To study the structure of anticoagulant prescription in a general hospital to identify trends ..." | ||
Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
O. D. Ostroumova, I. V. Goloborodova | ||
"... and quality of life of the patient. Anticoagulants, widely used in the treatment of thromboembolic ..." | ||
Vol 9, No 2 (2013) | ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS | Abstract similar documents |
O. V. Shatalova, O. N. Smuseva, A. S. Maslakov | ||
"... accounted for by indirect- acting anticoagulating agents — 66.7% (12/18), direct-acting anticoagulants — 22 ..." | ||
Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
"... The question of the safety of direct oral anticoagulants (DOACs), despite their high efficacy ..." | ||
Vol 18, No 1 (2022) | Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice | Abstract similar documents |
Yu. P. Skirdenko, N. A. Nikolaev, K. G. Pereverzeva, A. Yu. Timakova, A. S. Galus, S. S. Yakushin | ||
"... Aim. To assess the adherence of doctors and patients to anticoagulant therapy for atrial ..." | ||
Vol 12, No 4 (2016) | Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation | Abstract similar documents |
S. G. Kanorskii | ||
Vol 11, No 1 (2015) | ON THE SELECTION OF DRUGS DOSAGE REGIMEN | Abstract similar documents |
E. N. Bochanova | ||
Vol 11, No 2 (2015) | CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION | Abstract similar documents |
V. N. Shishkova | ||
Vol 11, No 6 (2015) | Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events | Abstract similar documents |
O. V. Shatalova | ||
Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
"... ) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke ..." | ||
Vol 14, No 4 (2018) | Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice | Abstract similar documents |
N. M. Vorobyeva, O. N. kacheva | ||
"... of anticoagulants in real clinical practice and questions of adherence of patients to anticoagulant therapy ..." | ||
Vol 4, No 2 (2008) | ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? | Abstract similar documents |
A. L. Komarov, E. P. Panchenko | ||
"... Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed ..." | ||
Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
A. I. Kochetkov, O. D. Ostroumova | ||
"... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
"... in direct oral anticoagulants (DOACs), the possibility of using which in LVT is being actively studied ..." | ||
Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
B. A. Tatarsky, N. V. Kazennova | ||
"... The last decade has dramatically changed the strategy of anticoagulant therapy in patients ..." | ||
Vol 18, No 3 (2022) | Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art | Abstract similar documents |
S. R. Gilyarevsky | ||
"... the efficacy and safety of the use of direct oral anticoagulants (DOACs) in clinical practice. Data on drug ..." | ||
Vol 13, No 5 (2017) | DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS | Abstract similar documents |
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov | ||
"... favorable profile of drug interaction in comparison with other new oral anticoagulants (NOAC). The basis ..." | ||
Vol 10, No 6 (2014) | THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | Abstract similar documents |
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev | ||
"... for anticoagulant prevention. Besides, heparin and warfarin use for VTE prevention in cancer is accompanied by some ..." | ||
Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
"... of oral anticoagulants (ОAC) in patients with atrial fibrillation (AF) in 2015-2017. Material and methods ..." | ||
Vol 19, No 3 (2023) | Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants | Abstract similar documents |
S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid | ||
"... to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical situations in which ..." | ||
Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
O. V. Averkov, L. N. Mishchenko | ||
"... Oral anticoagulant therapy is widely used in different patients for the prevention and treatment ..." | ||
Vol 5, No 1 (2009) | CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY | Abstract similar documents |
Yu. A. Bunin | ||
"... stratification) of different antiarrhythmic drugs and anticoagulants are described. Perspectives in improvement ..." | ||
Vol 12, No 4 (2016) | The use of oral anticoagulants in patients with atrial fibrillation: cohort study data | Abstract similar documents |
O. V. Gaisenok, A. S. Leonov | ||
"... Aim. To study the rate of prescription of oral anticoagulants (OAC) in patients with atrial ..." | ||
Vol 13, No 1 (2017) | DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT | Abstract similar documents |
D. А. Napalkov, A. A. Sokolova, V. V. Fomin | ||
"... anticoagulants, apixaban is associated with the best adherence to treatment and lowest bleeding incidence ..." | ||
Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
"... Aim. To study the structure and incidence of the in-hospital anticoagulants prescription ..." | ||
Vol 9, No 2 (2013) | ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES | Abstract similar documents |
Z. M. Safiullina, S. V. Shalaev | ||
"... Studies data on new anticoagulants, direct oral thrombin inhibitor (dabigatran) and direct ..." | ||
Vol 14, No 6 (2018) | Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem | Abstract PDF (Eng) similar documents |
N. M. Vorobyeva, O. N. Tkacheva | ||
"... The review focuses on the use of oral anticoagulants in fragile elderly patients. The issues ..." | ||
Vol 13, No 5 (2017) | Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells | Abstract similar documents |
Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov | ||
"... profile of drug interaction in comparison to other non-vitamin K antagonist oral anticoagulants (NOAC ..." | ||
Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
"... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
К. V. Lobastov, I. V. Schastlivtsev | ||
"... (VTE) in cancer patients. In accordance with actual guidelines, the duration of anticoagulant therapy ..." | ||
Vol 8, No 4 (2012) | THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY | Abstract similar documents |
M. Yu. Gilyarov | ||
Vol 16, No 6 (2020) | The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? | Abstract similar documents |
N. M. Vorobyeva, O. N. Tkacheva | ||
"... The administration of oral anticoagulants in elderly patients with geriatric syndromes ..." | ||
Vol 17, No 1 (2021) | Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction | Abstract similar documents |
Z. D. Kobalava, A. A. Shavarov, M. V. Vatsik-Gorodetskaya | ||
"... anticoagulant has unique pharmacologic properties of which clinician should be aware to optimally manage ..." | ||
Vol 12, No 3 (2016) | THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE | Abstract PDF (Eng) similar documents |
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko | ||
"... to anticoagulation therapy in these patients. Keywords: new oral anticoagulants, apixaban, pharmacokinetics, atrial ..." | ||
Vol 12, No 3 (2016) | THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT | Abstract PDF (Eng) similar documents |
S. R. Gilyarevskiy | ||
"... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..." | ||
Vol 13, No 5 (2017) | WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT | Abstract similar documents |
S. Yu. Martsevich, Y. V. Lukina | ||
"... Oral anticoagulant (OAC) therapy is currently gaining special importance due to the significant ..." | ||
Vol 7, No 3 (2011) | STROKE PREVENTION IN INTERNIST PRACTICE | Abstract similar documents |
D. A. Napalkov, A. V. Zhilenko | ||
"... guidelines. Modern pharmacotherapy includes antiaggregants or anticoagulants, statins, and antihypertensive ..." | ||
Vol 7, No 5 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES | Abstract similar documents |
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy | ||
Vol 15, No 6 (2019) | Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova | ||
"... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..." | ||
Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
"... Aim. To study the frequency of prescribing anticoagulant therapy in outpatients with AF ..." | ||
Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
"... are at high risk of stroke. The direct oral anticoagulants are indicated for them. The choice of a drug should ..." | ||
Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
"... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..." | ||
Vol 16, No 4 (2020) | The Controversy Continues Again: which Direct Anticoagulant is More Effective and Safe when Administered to Patients with Atrial Fibrillation? | Abstract similar documents |
S. Yu. Martsevich | ||
Vol 16, No 5 (2020) | Clinical Case of Complicated Thrombophilia in a Patient with Ulcerative Colitis | Abstract similar documents |
S. A. Boldueva, I. V. Yarmosh, A. N. Dolinova, Z. G. Kaloeva, M. Yu. Serkova, V. M. Avramova | ||
"... was continued. At the same time, anticoagulant therapy was started, and antibiotics were canceled. As a result ..." | ||
Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
"... in patients with acute coronary syndrome (ACS) undergoing anticoagulants for atrial fibrillation using ..." | ||
Vol 17, No 2 (2021) | Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage | Abstract similar documents |
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov | ||
"... Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy ..." | ||
Vol 15, No 4 (2019) | Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
"... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..." | ||
Vol 17, No 6 (2021) | Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 | Abstract similar documents |
A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov | ||
"... of direct oral anticoagulants increased in 2020 compared to 2016 (р<0.001). For patients with a high risk ..." | ||
Vol 17, No 6 (2021) | Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation | Abstract similar documents |
T. V. Pavlova | ||
"... approach to treatment, and their management is a complex clinical task. The direct oral anticoagulant ..." | ||
Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
"... Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow ..." | ||
Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
"... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..." | ||
Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
"... Background. Anticoagulants (AC) are the high-risk drugs. Their safety closely depends on physician ..." | ||
Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
"... Aim. To study the frequency of administration of direct oral anticoagulant (DOACs) in doses ..." | ||
Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
"... Aim. To assess the compliance of nephroprotective and anticoagulant therapy in patients ..." | ||
Vol 18, No 5 (2022) | Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
Z. A. Gebekova, I. I. Ivanov, A. Asambayeva, A. I. Skripka, A. A. Sokolova, D. A. Napalkov, T. A. Vuimo | ||
"... different direct oral anticoagulants (DOACs) using Thrombodynamics test. Materials and methods ..." | ||
Vol 13, No 6 (2017) | PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin | ||
"... the development of bleeding during anticoagulant therapy with direct oral anticoagulants (DOAC). Material ..." | ||
Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran ..." | ||
Vol 10, No 4 (2014) | FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW | Abstract similar documents |
S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva | ||
"... base and analysis of complications of different anticoagulants use for safety of sinus rhythm ..." | ||
Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
"... Aim. To study the efficacy, safety, and adherence to therapy with new oral anticoagulants ..." | ||
Vol 14, No 3 (2018) | THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE | Abstract similar documents |
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
"... long-term anticoagulant therapy with apixaban in a full dose (5 mg b.i.d.), and the patient ..." | ||
Vol 17, No 6 (2021) | Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 | Abstract similar documents |
I. S. Yavelov | ||
"... This review discusses reasons for prolonged use of anticoagulants after discharge of patients ..." | ||
Vol 20, No 4 (2024) | Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? | Abstract similar documents |
N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva | ||
"... ) and venous thromboembolic complications (VTE) should be avoided in favor of safer alternative anticoagulants ..." | ||
Vol 21, No 1 (2025) | Practical aspects of perioperative management in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants | Abstract similar documents |
E. N. Markova, T. Yu. Vedenikin, A. A. Kuzub, N. V. Kuchieva, A. R. Navasardyan, O. N. Dzhioeva | ||
"... fibrillation (AF) receiving direct oral anticoagulants (DOACs) and undergoing elective surgical interventions ..." | ||
Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
"... . In addition, they emphasize the role of anticoagulant therapy as a preventing tool for the development ..." | ||
Vol 17, No 4 (2021) | Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis | Abstract similar documents |
S. R. Gilyarevsky | ||
"... of real-life clinical trials to assess the effects of direct oral anticoagulants are discussed. ..." | ||
Vol 18, No 4 (2022) | Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants | Abstract similar documents |
D. V. Pevzner, N. S. Kostritca, A. K. Alieva, I. A. Merkulova, I. S. Yavelov, E. V. Merkulov, I. E. Chazova | ||
"... anticoagulants (DOACs) or warfarin. Material and methods. A prospective observational study included patients ..." | ||
Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
Yu. A. Bunin, S. V. Miklishanskaya | ||
"... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..." | ||
Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
S. G. Kanorskii | ||
"... Atrial fibrillation (AF) increases the risk of stroke, therefore long-term anticoagulant therapy ..." | ||
Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract similar documents |
T. V. Pavlova | ||
"... Anticoagulant therapy in elderly patients with atrial fibrillation and concomitant diseases ..." | ||
Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
"... with persistent nonvalvular atrial fibrillation receiving warfarin and direct oral anticoagulants (DOAC ..." | ||
Vol 12, No 2 (2016) | ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov | ||
Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
"... The choice of anticoagulant therapy in patients with atrial fibrillation (AF) and concomitant ..." | ||
Vol 21, No 1 (2025) | The Beers criteria role in predicting bleeding during the use of direct oral anticoagulants in patients with atrial fibrillation over 80 years of age | similar documents |
M. S. Cherniaeva, M. A. Rozhkova, E. S. Ilyina, E. A. Moiseeva, E. A. Gorelov, L. A. Egorova, O. M. Maslennikova, N. V. Lomakin, D. A. Sychev | ||
"... (КЗНК) на фоне приема прямых оральных антикоагулянтов. Материал и методы. Обследованы 367 пациентов ..." | ||
Vol 12, No 5 (2016) | Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms | Abstract PDF (Eng) similar documents |
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev | ||
"... level of adherence compared to patients without anticoagulants (65.2±19.3% vs 68.5±19.1%; Wald-Wolfowitz ..." | ||
Vol 17, No 2 (2021) | Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic | Abstract similar documents |
S. M. Mamatov, B. Kanat kyzy, A. O. Musakeev, N. K. Kinderbaeva, T. J. Tagaev | ||
"... Aim. To study the current state of the anticoagulant's prescription in elderly and senile patients ..." | ||
Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
"... therapy with the addition of direct oral anticoagulants (DOAC). Material and methods. An open-label ..." | ||
Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
"... with anticoagulants to prevent an ischemic stroke and systemic thromboembolisms. However, in case of combination AF ..." | ||
Vol 13, No 6 (2017) | ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY | Abstract similar documents |
Yu. А. Bunin, S. V. Miklishanskaya | ||
"... antiarrhythmics and not antiarrhythmic drugs, anticoagulants and non-drug treatments in these patients. Based ..." | ||
Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... ) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists ..." | ||
Vol 11, No 3 (2015) | PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT | Abstract similar documents |
A. V. Rudakova | ||
"... or oral anticoagulants that differ significantly in their efficacy, safety and cost of the therapy. Aim ..." | ||
1 - 100 of 219 Items | 1 2 3 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)